InsiderTrades

Form 4/A for MDT Medtronic

Accepted 2025-03-10 00:00:00 ET · period of report 2025-03-03 · accession 0001613103-25-000032 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMA 2025-03-10 2025-03-03 MDT Pieton Thierry EVP, CFO A - Grant $0.00 +30.8K 4,242 New $0
DA 2025-03-10 2025-03-03 MDT Pieton Thierry EVP, CFO A - Grant $0.00 +29.6K 29.6K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2025-03-03 A A 26,512 $0.00 30,754 D — — (F2) Form 4 filed 3/5/2025 reported incorrect pricing information for restricted stock units due to an administrative error. The purpose of this amendment is to reflect that restricted stock units were received as a grant, for no consideration.
2 Common Ordinary Shares 2025-03-03 A A 4,242 $0.00 4,242 D — — (F1) Form 4 filed 3/5/2025 reported incorrect vesting information for restricted stock units due to an administrative error. The purpose of this amendment is to correct the vesting description to state: Represents restricted stock units that vest 100% on July 29, 2027. (F2) Form 4 filed 3/5/2025 reported incorrect pricing information for restricted stock units due to an administrative error. The purpose of this amendment is to reflect that restricted stock units were received as a grant, for no consideration.
3 Derivative Stock Option (Right to Buy) 2025-03-03 A A 29,574 $0.00 29,574 D $94.30 · — to 2035-03-03 29,574 Ordinary Shares (F3) Form 4 filed 3/5/2025 reported incorrect vesting information for options due to an administrative error. The purpose of this amendment is to correct the vesting description to state: The options are exercisable in four equal annual installments on July 29th of 2025, 2026, 2027 and 2028.